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The effects of dietary fatty acids on the proliferation of normal human
urothelial cells in vitro
J Southgate, E Pitt and LK Trejdosiewicz
ICRF Cancer Medicine Research Unit, St James's University Hospital, Leeds LS9 7TF, UK.
Summary Little is known of the mechanisms by which dietary fatty acids (FAs) may affect normal epithelial
cell physiology and thereby directly or indirectly influence tumour incidence and progression. In this study, we
have used normal human urothelial cell cultures to investigate whether FAs may modify proliferation of
normal human epithelial cells in vitro. FAs were presented as albumin complexes in serum-free medium and the
effects on proliferation over a concentration range of 1-100 gM were assayed by thymidine incorporation.
Saturated FAs had no effect. At lower concentrations (1-10 gM), mono-unsaturated FAs (MUFAs) and n-3
polyunsaturated FAs (PUFAs) were slightly stimulatory. Concentrations of unsaturated FAs above 10 pm were
growth inhibitory in a dose-dependent manner. Oleic acid showed least cytostatic effect, whereas y-linolenic
acid induced irreversible growth arrest. Although marked morphological effects were observed in irreversibly
growth-inhibited cells, the cells remained attached to the substratum and showed no evidence of nuclear
pyknosis or apoptosis. The inhibitory effects of single PUFAs could be reduced, but not abolished, by the
addition of saturated FAs or MUFAs. Mixtures of different PUFAs were inhibitory in an additive manner.
These data suggest that PUFAs have a cytostatic effect on rapidly proliferating epithelial cells which appears
unrelated to malignant transformation.
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The past 30 years have seen significant changes in the western
dietary intake of fatty acids (FAs). To an extent this change
has been driven by indications that an increase in the ratio of
polyunsaturated (PUFA) to saturated FAs in the diet may
reduce coronary disease. Evidence that the dietary intake of
FAs may also affect cancer incidence is largely epidemiolo-
gical but implicates a high fat intake with increased risk of
colon and breast cancer (reviewed by Narisawa et al., 1994;
Reddy, 1994). There is further epidemiological evidence to
suggest that the low incidence of breast and colon cancer seen
among traditional Mediterranean, Inuit or Japanese popula-
tions may be related respectively to diets high in mono-
unsaturated oleic acid or fish-based diets high in
polyunsaturated n-3 FAs (reviewed in Narisawa et al., 1994;
Reddy, 1994). Despite inherent problems associated with
human controlled feeding studies and in extrapolating human
diets to animal models, these observations are finding some
support in human trials (Dolecek and Granditis, 1991) and in
rodent systems (reviewed in Kromhout, 1990; Narisawa et al.,
1994).
The mechanism(s) by which FAs may suppress or enhance
tumour development are unclear. On the basis of animal
studies, several hypotheses have been put forward to explain
why polyunsaturated n-3 FAs might be tumour suppressive,
including reduced sensitivity to tumour promoters as a
consequence of changes in membrane lipid composition
(Narisawa et al., 1991). It has also been shown that a n-3
PUFA-rich diet can reduce the proliferation rate of normal
colonic crypt epithelial cells (Anti et al., 1992; Bartram et al.,
1993; Pell et al., 1994). As reduced normal cell proliferation
may confer protection against the development of cancer
(Preston-Martin et al., 1990), this raises the intriguing
possibility that PUFAs may be inhibitory to all rapidly
proliferating epithelial cells, rather than just malignantly
transformed carcinoma cells.
In order to address this question, we have taken advantage
of our system for the in vitro propagation of normal human
epithelial cells of urinary tract origins. We have shown
previously that normal urothelial cells can be isolated from
urinary bladder, ureter and renal pelvis and maintained in a
highly proliferative state in serum free culture (Hutton et al.,
1993; Southgate et al., 1994). Urothelial cells are the
precursors of transitional cell carcinoma (TCC), the
incidence of which generally mirrors the incidence of breast
and colon cancer (Whelan et al., 1990; Parkin et al., 1993)
and for which exogenous risk factors have been identified as
important. Thus, we have used the urothelial model to study
the effects on normal epithelial cell proliferation of
physiologically presented saturated, monounsaturated
(MUFA) and n-3 and n-6 polyunsaturated FAs of 18-22
carbon chain length.
Materials and methods
Normal urothelial cell culture
Urothelial tissues were obtained from the upper and lower
urinary tract of children undergoing open urological
operations for non-malignant conditions. Using our pre-
viously described procedures (Southgate et al., 1994),
urothelial cell sheets were isolated from the stroma by
overnight incubation at 4°C in Hanks' balanced salt solution
containing 10 mM Hepes pH 7.6, 0.1% (w/v) EDTA and
20 kIU aprotinin. The urothelial cell sheets were disaggre-
gated by incubation for 20 min in 100 U ml-' collagenase
type IV (Sigma, Poole, UK) and the cells were seeded into
'Primaria' tissue culture flasks (Becton Dickinson, Cowley,
UK) at a minimum density of 4 x 104 cells cm-2 in
'keratinocyte serum-free medium' (KSFM) containing re-
combinant epidermal growth factor and bovine pituitary
extract at the manufacturer's recommended concentrations
(Gibco BRL, Paisley, UK) and cholera toxin at 30 ng ml-'.
Cultures were passaged at just confluence using trypsin/
EDTA to detach cells as previously described (Southgate et
al., 1994), and replated as required. The studies described
here were carried out on cultures established from nine
independent donors and used between passages 3 and 6.
Preparation of FA -BSA complexes
In order to mimic the physiological route of FA presentation
to cells via the serum, FA complexes with bovine serum
albumin (BSA) were prepared, using essentially fatty acid-free
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BSA (Sigma). Complexes were prepared with stearic acid
(18:0), oleic acid (18:1 n-9), linoleic acid (18:2 n-6), v-
linolenic acid (GLA; 18: 3 n-6), a-linolenic acid (ALA; 18: 3
n-3), eicosapentaenoic acid (EPA; 20: 5 n-3) and docosahex-
aenoic acid (DHA; 22:6 n-3), using a biphasic heptane base
conjugation and separation technique (Spector et al., 1969).
All reactions and procedures were performed in the dark
under an atmosphere of nitrogen in order to protect the FAs
from oxidation and/or photodegradation. After conjugation,
FA -BSA complexes were dialysed extensively against
distilled water and lyophilised. BSA for control cultures
was processed through a mock conjugation/separation
protocol. The complexes were stored dehydrated and were
freshly reconstituted in medium as required. The solutions
were filter sterilised through 0.2 gm Acrodisc filters (Gelman
Sciences, Northampton, UK) before use.
The FA-BSA complexes were analysed using a proprie-
tary spectrophotomeric assay for non-esterified FA supplied
by Randox Laboratories (Ardmore, Co. Antrim, Ireland).
Analysis of the growth medium determined the baseline
concentration of FA to be between 0.4 and 1.9 JgM. All cell
culture experiments were performed using the BSA-com-
plexed FA and the final BSA concentration of the medium
(including the no FA control) was always adjusted to
10 mg ml-' using FA-free (mock-conjugated) BSA.
Analysis of cell morphology
Cells were plated at an initial density of 2 x 104 cells cm-2
onto 35 mm 'Primaria' Petri dishes (Becton Dickinson). After
cell attachment (within 3 h of plating), cultures were exposed
to a range of concentrations of FA, as specified below. The
cultures were propagated for a 72 h period, photographed by
inverted phase microscopy and fixed either in formal-
calcium for 20 min before staining with Sudan IV lipid
stain or fixed in a 1: 1 mixture of methanol and acetone
(MA), air dried and stained in haematoxylin and eosin. In
order to observe apoptotic bodies, MA-fixed cell monolayers
were briefly stained with 10 jg ml-' acridine orange
(Gregory et al., 1991) and viewed in a Zeiss Axioplan
microscope using immersion objectives, epifluorescent illumi-
nation and dual colour red/green filter set no. 22.
Cell proliferation assays
Urothelial cells were plated in 96-well plates (Linbro, ICN
Flow Laboratories, Horsham, UK) at an initial plating
density of 1 x 104 cells per well in KSFM growth medium.
After cell attachment, the FA-BSA complexes were added to
the wells in replicates of six. A 'no FA' and a 'BSA (fatty-
acid free) only' control series was included in all experiments.
Cells were cultured for a total period of 72 h in the
presence of the FA. Aliquots of 0.5 jiCi per well of tritiated
thymidine (Amersham, Little Chalfont, UK) were added for
the final 18 h incubation period. To enable efficient cell
harvest, cells were preincubated in 0.1% (w/v) EDTA in
phosphate-buffered saline (PBS) for 60 min at 37°C before
semi-automated harvest [Pharmacia Wallac (UK), Milton
Keynes] of DNA-incorporated radionucleotide onto glass-
fibre filter mats for analysis of thymidine incorporation using
a Beta-plate liquid scintillation spectrometer (Wallac).
Dose and combination studies of FA on cell proliferation
The effects of individual FAs on cell morphology and
proliferation were studied at concentrations of 0, 1, 10, 30
and 100 JuM above the baseline FA concentration of the
medium (above). These experiments were performed on six
independent normal urothelial cell lines. In order to
determine whether the effects of FA were reversible after
72 h culture, cells were either harvested by trypsinisation and
replated in medium with or withour FA, or the media were
simply aspirated and replaced in subconfluent cultures.
In some experiments, PUFAs (linoleic acid, GLA, EPA
and DHA) were used respectively in combination with either
stearic acid or oleic acid at ratios of 1:1 (15 ,UM each) and
10: 1 (30 JuM and 3 JgM). For these combination experiments,
baseline data were obtained from parallel cultures exposed to
each of the individual FAs at the relevant concentrations.
Experiments were performed on at least two independent cell
lines.
Combinations of two FAs (stearic acid with EPA, stearic
acid with linoleic acid, linoleic acid with EPA) were also
tested in a series in which the total FA concentration was
kept constant at 100 JgM and the two individual FAs were
added at reciprocal concentrations of 0-1I00 gM in incre-
ments of 10.
A final series of experiments tested the effects of
combinations of three or four FAs on cell proliferation.
The total concentration of FA in each experiment was either
30 ,uM or 100 JgM (two independent cell lines each) and the
ratios of FAs in each combination was based broadly on
ratios of free unsaturated (stearic acid): mono-unsaturated
(oleic acid): polyunsaturated n-6 (linoleic acid) and poly-
unsaturated n-3 (EPA) FA found either in the human
circulation (Lentner, 1984) or based on ratios typical of
'traditional' Italian, Finnish, American, Japanese and
vegetarian diets (Table I) from studies of dietary fat intakes
and plasma levels of free FA (Dougherty et al., 1987; Garton
et al., 1992; Agren et al., 1995). The other combinations were
based on n-3- and n-6-rich diets from the work of Narisawa
et al. (1991 and 1994).
Calculations and statistical analysis
Results of all [3H]thymidine incorporation assays were
expressed as 'growth indices' where
Growth index = mean c.p.m. (no FA control)/mean c.p.m.
test (with FA)
after background subtraction
Means and 95% confidence intervals were used as
descriptive statistics. Statistical significance for individual
test vs control replicates was determined by Student's t-test
(two-tailed, assuming variances not equal). For comparison
of overall effects between experiments, one-way ANOVA
(analysis of variance) was carried out with post-test
significance values corrected by the Bonferroni method for
multiple comparisons.
Results
Effects of individual FA on cell morphology
Normal urothelial cells grew as monolayers of adherent cells
with a regular polygonal epithelioid morphology. The
addition of BSA alone or BSA-complexed FA to the
medium of normal urothelial cell cultures produced no
Table I Relative combinations of FA used to mimic specific diet
types
Saturated MUFA n-6 PUFA
(stearic (oleic n3 PUFA (linoleic
acid) acid) (EPA) acid)
Physiological serum
Concentrations 40 40 5 15
Diet
Italian 30 60 0 10
Finnish 55 30 0 15
United States 40 40 0 20
Japanese 40 40 10 10
Vegetarian 20 30 0 50
High n-6 10 20 5 65
High n-3 10 20 55 15
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changes in cell morphology at FA concentrations of up to
10 gM (Figure la). At higher concentrations, morphological
changes observed were dependent on FA type: cells grown
with stearic acid were rounded and had lost some of their
regular polygonal appearance, whereas cells grown with oleic
acid showed a more elongated morphology (Figure lb). After
exposure to PUFA, cells became spindle-shaped with long
filopodial processes between adjacent cells (Figure lc). The
most marked changes were noted with GLA (Figure ld),
whereas ALA showed only minor changes. All morphological
changes were more marked at 100 gLM than 30 gM FA and
were accompanied by a dose-dependent increase in cytoplas-
mic granularity. Staining of cell monolayers with Sudan IV
demonstrated that the increase in granularity was owing to
the accumulation of lipid inclusion bodies in the cytoplasm
(Figure le-f).
The marked morphological changes were not accompanied
by marked detachment of cells from the monolayer. Nuclei
retained prominent nucleoli and there was no evidence of
either nuclear pyknosis of apoptotic nuclear fragmentation in
any cells, as judged by acridine orange or haematoxylin and
eosin staining.
Effects of individual FAs on cell proliferation
Stearic acid had no effect on cell proliferation over a 1-
100 gUM concentration range. The mono-unsaturated oleic
acid showed a slight enhancement of thymidine incorporation
at 10 giM concentration (P<0.001 by t-test), but at higher
concentrations was growth suppressive (P<0.001, ANOVA),
inhibiting thymidine uptake to approximately 60% of control
at 100 ,UM oleic acid (Figure 2).
...
Figure 1 Phase-contrast micrographs of normal human urothelial cells cultured for 72h in the presence of 100/IM FA-BSA
complexes. BSA concentrations were kept constant at 10mgml-. Note that cells remained attached to the substrate even although,
in c and d, the cells failed to incorporate thymidine. (a) No FA control. Cells show typical polygonal epithelioid morphology. (b)
Oleic acid. Cells appear more elongated than in a. (c) EPA. There is loss of the typical epithelioid pavement morphology and many
cells are spindle-shaped with long filipodial processes. (d) GLA. The majority ofcells are spindle-shaped with long cellular processes
apparent. (e and f) Sudan IV stained monolayers of normal human urothelial cells showing lipid inclusions in cells maintained
without FA (e) or in the presence of 100gM GLA (f) for 72h. Scale bar 100ipm.PUFAs at concentrations of up to 10 gM either had no
effect (linoleic acid and GLA) relative to the albumin control,
or showed a small enhancement of thymidine incorporation
between 1 and 10 gM (ALA, EPA and DHA). This mitogenic
effect was significant by t-test (P<0.001), but not by the
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much more stringent ANOVA with Bonferroni correction. At
PUFA concentrations of >30 gM, there was a decrease in
thymidine incorporation in all cases. The inhibition at 30 gM
FA was small with ALA and DHA, but thymidine
incorporation was reduced to approximately 50% of control
Oleic acid (18:1 n-9)
0.5 V
o0Ll i , // 111111 .1 .1
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Figure 2 Effects of single FA on thymidine incorporation into urothelial cells. Results of [3H]thymidine incorporation experiments
performed on at least six independent normal urothelial cell lines are expressed as growth indices: the incorporation ratios relative to
BSA-only (no FA) controls. The points and error bars represent means+95% confidence intervals. (*P<0.001 by t-test. P<0.001
by t-test and ANOVA with Bonferroni correction).
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with linoleic acid or EPA, and to 20% of control with GLA,
which showed the most inhibitory effect. At 100 giM,
thymidine incorporation relative to control was reduced to
below 40% with ALA and DHA and to below 10% with
linoleic acid, GLA and EPA. The PUFA-inhibitory effects at
high concentrations were all highly significant (summarised in
Figure 2).
Stearic and oleic acids had no long-term effects on the
proliferation or viability of normal human urothelial cells:
cells grown for 72h in either FA could subsequently survive
passage to reach confluence at the same time as control cells
grown without FA. By contrast, the effects of linoleic acid,
GLA, EPA or DHA on cell proliferation were irreversible
and the PUFA-treated cells did not reach confluence when
replated, even if the medium no longer contained FA. The
only exception to this was seen with ALA, which showed
recovery of proliferation following removal of the FA from
the medium.
Effect ofpairs of FA on cell proliferation
The possibility that saturated FA or MUFA could overcome
the inhibitory effects of PUFA was examined by using
mixtures of FA pairs. Where a PUFA was used in
combination with either stearic acid or oleic acid, there was
some reduction in the inhibitory effects of the PUFA, but
neither the saturated FA nor the MUFA was able to
overcome the inhibition fully. This was the case even when
the two FAs were used in equimolar ratios and the PUFA
was used at a concentration of 15 guM, where the inhibitory
effects were submaximal.
To investigate this phenomenon further, stearic acid was
tested across a reciprocal range of concentrations against
linoleic acid or EPA. Stearic acid was found to modulate the
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Figure 3 Effects of reciprocal concentrations of fatty acids (bar
charts), compared with the effects of the single fatty acids
(symbols and dotted lines), on [3H]thymidine incorporation.
Results are expressed as growth indices relative to the BSA-only
controls and means+95% confidence intervals are plotted.
inhibitory effects of both PUFAs and reduced the growth
inhibitory effects of both the n-3 and n-6 PUFAs to some
extent, even when present as only 10% of the total FA
(Figure 3). By contrast, the inhibitory effects of linoleic acid
and EPA were found to be additive, such that the total
concentration of PUFA determined the degree of inhibition
of thymidine incorporation (Figure 3).
Effect of multiple FA combinations on cellproliferation
Where the total FA concentration was limited to 30 g1M, there
was a significant decrease in thymidine incorporation in FA
concentrations in which PUFA was the major component(s)
(> 70% of total). The effect was independent of whether the
PUFA was predominantly in the form of n-3 or n-6 (Figure
4). At 100 gM total FA concentration, the inhibition of
thymidine incorporation also became evident in the 'diet'
mixture in which PUFA accounted for 50% of control.
However, where the majority of the mixture was in the form
of saturated or mono-unsaturated FA, there was no
significant difference from the no FA control at either 30
or 100 gIM total FA (Figure 4).
Discussion
There is a consensus in the literature that PUFAs inhibit the
growth of carcinoma cells in vitro. However, it is less clear
whether these effects relate to cell proliferation rate per se, or
to a consequence of the malignant transformation process of
epithelial cells. Although several studies have shown
x
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Figure 4 Effect of complex FA mixtures on urothelial cell
proliferation. Mixtures of four FAs totalling final concentrations
of either 30MM (a) or 10OMM (b) were used representative of
specific diets (see Table I). Results are expressed as growth indices
relative to BSA-only controls and means+95% confidence
intervals are plotted. P<0.001 by t-test. **P<0.001 by t-test
and ANOVA with Bonferroni correction.differential effects of FAs on human transformed vs non-
transformed cells in vitro, such studies have either related the
effects of FA on carcinoma cells to fibroblasts (Begin et al.,
1986) or to an immortalised breast carcinoma-derived cell
line (Grammatikos et al., 1994) as the 'non-cancerous'
counterpart. Clearly, neither case can offer a true reflection
of the effects of FAs on normal epithelial cell proliferation.
Our study is one of the first to report on the in vitro effects of
FAs on normal human adult epithelial cells and our
observations suggest that there are marked similarities in
the responses to FAs of normal proliferating epithelial cells
compared with studies involving carcinoma-derived cell lines.
This is in agreement with studies of the effects of dietary FAs
on proliferation of normal cells in vivo, which have also
demonstrated that diets high in PUFAs can be anti-mitotic
for the normally rapidly proliferating epithelial cells in
intestinal crypts (Anti et al., 1992; Bartram et al., 1993; Pell
et al., 1994).
We have used free (non-esterified) FAs in the form of
albumin-bound complexes as this is the physiological mode
of presentation to normal cells in vitro. This hinders
comparison with other approaches, such as the use of FAs
in ethanol solution (Rose and Connolly, 1990; DeKoch et al.,
1994; Hatala et al., 1994; Sylvester et al., 1994; Maehle et al.,
1995). Nevertheless, almost all authors have reported that
both n-3 and n-6 PUFAs inhibit growth of cells in vitro in an
irreversible, dose-dependent manner. The one exception is the
study of Sylvester et al. (1994), which showed stearic acid to
be growth inhibitory and n-6 arachidonic acid to be
stimulatory in mouse mammary epithelial cells respectively.
In agreement with the observations made by Falconer et al.
(1994) on human pancreatic adenocarcinoma cell lines, it
appears that, at low concentrations, FAs may show a small
enhancement of epithelial cell proliferation. Furthermore, in
both this and the study by Falconer et al. (1994), different
FAs were shown to interact to modulate overall cell response,
implying that the actual composition of FAs in a diet may be
significant. Specifically, we found the inhibitory effects of
PUFAs to be additive, whereas addition of saturated FAs or
MUFAs could, to some extent, overcome the inhibitory
effects of PUFAs. This resembles the oleic acid-inducible
reversal of the cytotoxic effects on pancreatic carcinoma cells
reported by Falconer et al. (1994), although they found no
effects with stearic acid.
From our data and the observations of others, we suggest
that epithelial cell sensitivity to the cytostatic effects of
PUFAs may be a function of proliferative activity and hence
is not necessarily related to malignant transformation.
Although the urothelium is a very slow turnover epithelium
in situ, it is capable of very rapid proliferation rates both
during regeneration in vivo (Marceau, 1990) and when grown
in vitro, where we have shown the doubling time to be in the
order of 15 h (Southgate et al., 1994). Hence, in studies where
normal, immortalised or cancerous cell lines have been
compared (Cantril et al., 1993; Grammatikos et al., 1994),
it was not clear whether there are underlying differences in
proliferation rates which may account for differences in
sensitivity to the cytostatic and cytotoxic effects of PUFAs.
It has been proposed that the differential effects of PUFAs
on tumour cells may reflect decreased desaturase activity and
hence an increased metabolic requirement for exogenous FAs
(discussed by Grammatikos et al., 1994). However, in normal
peripheral blood lymphocytes, where dividing and non-
dividing cell populations can be compared, it has been
shown that mitogenesis is accompanied by a rapid and
sustained increase in the polyunsaturation of the plasma
membrane (Shires et al., 1989). Hence, apparent differences in
metabolism between normal and tumour cells may reflect
proliferation rates, rather than any intrinsic property of
carcinoma cells. Although our study was not designed to
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address the differential effects of n-3 and n-6 PUFAs on
tumorigenesis, the data do suggest that n-6 PUFAs are more
cytostatic to normal cells than n-3 PUFAs of an equivalent
18 carbon chain length. There was also a closer similarity in
the dose-related response characteristics of normal urothelial
cells to the 18C mono-unsaturated oleic and C18 n-3 ALA,
than to either of the C18 n-6 PUFAs tested.
As noted above, the in vivo data would suggest that diets
high in fish oils might protect against tumour development
(Anti et al., 1992) and growth (Narisawa et al., 1994) and can
inhibit normal epithelial cell proliferation in colonic crypts
(Bartram et al., 1993; Pell et al., 1994). Although the effects
offish oils have been attributed to the n-3 PUFAs, it must be
remembered that fish oils typically contain less than 50% of
n-3 PUFAs and it has been pointed out that care should be
taken when attributing effects to single fatty acids when
complex mixtures of oils are administered (Garton, 1992). In
our experiments with complex mixtures, effects attributable to
PUFAs were only observed where the PUFAs contributed to
more than 50% of the total fatty acids and were very much
more pronounced at high FA concentrations. Our data
suggest that PUFAs of both n-3 and n-6 types may be growth
inhibitory and therefore any differential effects of n-3 vs n-6
PUFAs on cell growth in vivo might be attributable to
additional factors.
In addition to a potential role in colon cancer prevention
(Anti et al., 1992), there is considerable interest in exploiting
the dietary effects of n-3 PUFAs as an adjunct to
conventional cancer therapy (reviewed by Das, 1990; Burns
and Spector, 1994). However, our findings advocate caution
if the targets are proliferating rather than specific tumour cell
populations, as such an approach would offer no advantage
over other conventional chemotherapy or radiotherapy
regimens. In this context, it is of interest that the PUFAs
appeared to irreversibly arrest growth in the normal cells in a
way that is very reminiscent of mitomycin-C treatment or
radiation-induced 'reproductive cell death', resulting in intact
monolayers of non-dividing cells. Although the specific
cytostatic mechanism was not explored here, it has been
suggested that increased free radical generation through lipid
peroxidation may be involved (Begin et al., 1986; 1988). It
has been reported that short-chain FAs may kill colonic
tumour cells by inducing apoptosis (Hague et al., 1995).
Using morphological criteria, we did not observe apoptotic
cells in normal urothelial cells treated with high concentra-
tions oflong-chain (18 -22 carbon) PUFAs. Although further
specific studies would be required, these observations suggest
that short-chain FAs may have a different mode of action or
induce apoptosis specifically in malignantly transformed cells.
Alternatively, this may reflect a biological difference between
epithelial cells of intestinal and urothelial origins, as there is
good evidence that apoptosis is a central mechanism for
normal epithelial cell turnover in the intestinal tract (Hall et
al., 1994).
In conclusion, we suggest that normal human epithelial
cells show considerable sensitivity to PUFAs that probably
relates to proliferation rate in vitro, rather than reflecting any
intrinsic differences between epithelial cells and their
malignantly transformed carcinoma counterparts.
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